Literature DB >> 19309283

A novel MECP2 gene mutation in a Tunisian patient with Rett syndrome.

Nourhène Fendri-Kriaa1, Zaineb Abdelkafi, Imen Ben Rebeh, Fatma Kamoun, Chahnez Triki, Faiza Fakhfakh.   

Abstract

Patients with classical Rett show an apparently normal psychomotor development during the first 6-18 months of life. Thereafter, they enter a short period of developmental stagnation followed by a rapid regression in language and motor development. Purposeful hand use is often lost and replaced by repetitive, stereotypic movements. Rett syndrome (RTT) is an X-linked dominant disorder caused frequently by mutations in the methyl-CpG-binding protein 2 gene (MECP2). The aim of this study was to search for mutations in MECP2 gene in two Tunisian patients affected with RTT. The results of mutation analysis revealed mutations in exon 4 of MECP2 gene in the two patients. In one patient we identified a new mutation consisting of a deletion of four bases (c.810-813delAAAG), which led to a frame shift and generated a premature stop codon (p.Lys271Arg fs X15) in transcriptional repression domain-nuclear localization signal (TRD-NLS) domain of MeCP2 protein. With regard to the second patient, a previously described transition (c.916C>T) that changed an arginine to a cysteine residue (p.R306C) in TRD domain of MeCP2 protein was revealed. In conclusion, a new and a known de novo mutation in MECP2 gene were revealed in two Tunisian patients affected with RTT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309283     DOI: 10.1089/gtmb.2008.0076

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  1 in total

1.  Combined in Silico Prediction Methods, Molecular Dynamic Simulation, and Molecular Docking of FOXG1 Missense Mutations: Effect on FoxG1 Structure and Its Interactions with DNA and Bmi-1 Protein.

Authors:  Marwa Kharrat; Chahnez Charfi Triki; Olfa Alila-Fersi; Olfa Jallouli; Bassem Khemakham; Salma Mallouli; Marwa Maalej; Marwa Ammar; Fakher Frikha; Fatma Kamoun; Faiza Fakhfakh
Journal:  J Mol Neurosci       Date:  2022-06-02       Impact factor: 2.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.